Breakthrough Chemistry, Inc.
BKTH
$0.16
-$0.02-11.11%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | 37.41% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 37.41% | -- | -- | -- | |
| Cost of Revenue | 102.27% | -- | -- | -- | |
| Gross Profit | -75.00% | -- | -- | -- | |
| SG&A Expenses | 51.18% | -- | -- | -- | |
| Depreciation & Amortization | 15.42% | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 43.06% | -- | -- | -- | |
| Operating Income | -43.42% | -- | -- | -- | |
| Income Before Tax | -18.40% | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -18.40% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -18.40% | -- | -- | -- | |
| EBIT | -43.42% | -- | -- | -- | |
| EBITDA | -53.34% | -- | -- | -- | |
| EPS Basic | -9.13% | -- | -- | -- | |
| Normalized Basic EPS | -9.23% | -- | -- | -- | |
| EPS Diluted | -9.13% | -- | -- | -- | |
| Normalized Diluted EPS | -9.23% | -- | -- | -- | |
| Average Basic Shares Outstanding | 7.57% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 7.57% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |